Evaluation of minimal residual disease in childhood ALL-Reference-Cited by-同舟云学术

Evaluation of minimal residual disease in childhood ALL

Published:2018-05 Issue: Volume:40 Page:104-108
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int J Lab Hem

Author:

Béné Marie C.¹,Eveillard Marion¹

Affiliation:

1. Hematology Biology; CHU Nantes; Nantes France

Publisher

Wiley

Subject

Biochemistry, medical,Clinical Biochemistry,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijlh.12835/fullpdf

Reference46 articles.

1. Childhood acute lymphoblastic leukemia: progress through collaboration;Pui;J Clin Oncol,2015

2. Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation;Brüggemann;Hematology Am Soc Hematol Educ Program,2017

3. Treatment of pediatric acute lymphoblastic leukemia;Cooper;Pediatr Clin North Am,2015

4. A revised definition for cure of childhood acute lymphoblastic leukemia;Pui;Leukemia,2014

5. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL);Bene;Leukemia,1995

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of CD73 on leukemic blasts increases during follow-up – a promising candidate marker for minimal residual disease detection in pediatric B-cell precursor acute lymphoblastic leukemia;Central European Journal of Immunology;2022

2. Hematological malignancies and molecular targeting therapy;European Journal of Pharmacology;2019-11